Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|February 18, 2026
Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden settingHumphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland, et al.
Plos One|February 6, 2014
The candidate TB vaccine, MVA85A, induces highly durable Th1 responsesMichele Tameris, Hennie Geldenhuys, Angelique KanyKany Luabeya, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
The European Respiratory Journal|March 24, 2018
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translationMunyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, et al.
Vaccine|June 10, 2026
The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial designAlemnew F Dagnew, Alexander C Schmidt, Amy Cinar, et al.
Plos One|November 12, 2015
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine TrialErick Wekesa Bunyasi, Michele Tameris, Hennie Geldenhuys, et al.
PLOS Global Public Health|September 7, 2023
Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19Renée Codsi, Nicole A Errett, Angelique K Luabeya, et al.
Frontiers in Immunology|July 18, 2018
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of <i>Mycobacterium tuberculosis</i> InfectionErin Logan, Angelique Kany Kany Luabeya, Humphrey Mulenga, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
High-sensitivity detection of <i>Mycobacterium tuberculosis</i> DNA in tongue swab samplesAlaina M Olson, Rachel C Wood, Kris M Weigel, et al.
Journal of Clinical Microbiology|January 2, 2025
High-sensitivity detection of <i>Mycobacterium tuberculosis</i> DNA in tongue swab samplesAlaina M Olson, Rachel C Wood, Kris M Weigel, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|February 18, 2026
Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden settingHumphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland, et al.
Plos One|February 6, 2014
The candidate TB vaccine, MVA85A, induces highly durable Th1 responsesMichele Tameris, Hennie Geldenhuys, Angelique KanyKany Luabeya, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
The European Respiratory Journal|March 24, 2018
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translationMunyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, et al.
Vaccine|June 10, 2026
The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial designAlemnew F Dagnew, Alexander C Schmidt, Amy Cinar, et al.
Plos One|November 12, 2015
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine TrialErick Wekesa Bunyasi, Michele Tameris, Hennie Geldenhuys, et al.
PLOS Global Public Health|September 7, 2023
Preferences of healthcare workers using tongue swabs for tuberculosis diagnosis during COVID-19Renée Codsi, Nicole A Errett, Angelique K Luabeya, et al.
Frontiers in Immunology|July 18, 2018
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of <i>Mycobacterium tuberculosis</i> InfectionErin Logan, Angelique Kany Kany Luabeya, Humphrey Mulenga, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
High-sensitivity detection of <i>Mycobacterium tuberculosis</i> DNA in tongue swab samplesAlaina M Olson, Rachel C Wood, Kris M Weigel, et al.
Journal of Clinical Microbiology|January 2, 2025
High-sensitivity detection of <i>Mycobacterium tuberculosis</i> DNA in tongue swab samplesAlaina M Olson, Rachel C Wood, Kris M Weigel, et al.
Pageof 23